Novel SDHD gene mutation (H102R) in a patient with metastatic cervical paraganglioma effectively treated by peptide receptor radionuclide therapy

Poeppel, Thorsten D; Yuece, Ali; Boy, Christian; Metz, Klaus A; Kaminsky, Elke; Neumann, Hartmut P; Rosenbaum, Sandra J; Mann, Klaus; Moeller, Lars C (2011). Novel SDHD gene mutation (H102R) in a patient with metastatic cervical paraganglioma effectively treated by peptide receptor radionuclide therapy. Journal of clinical oncology, 29(33), e812-5. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2011.36.2269

Full text not available from this repository.

Item Type:	Journal Article (Further Contribution)
Division/Institute:	04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine
UniBE Contributor:	Boy, Christian
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 14:19
Last Modified:	05 Dec 2022 14:05
Publisher DOI:	10.1200/JCO.2011.36.2269
PubMed ID:	22025150
Web of Science ID:	000297257400005
URI:	https://boris.unibe.ch/id/eprint/6163 (FactScience: 211065)